LB
29
-4
ORLY
47
2
DUK
55
-2
FMC
16
6
HIG
63
-4
SJM
16
2
MRK
68
2
MDT
53
-2
DG
72
4
ETN
57
-3
GE
77
-2
ADT
50
2
FLS
61
-2
LYB
23
3
MO
48
-9
NRG
52
2
NEE
54
2
XRAY
31
3
HAS
68
2
PRU
57
-2
LB
29
-4
ORLY
47
2
DUK
55
-2
FMC
16
6
HIG
63
-4
SJM
16
2
MRK
68
2
MDT
53
-2
DG
72
4
ETN
57
-3
GE
77
-2
ADT
50
2
FLS
61
-2
LYB
23
3
MO
48
-9
NRG
52
2
NEE
54
2
XRAY
31
3
HAS
68
2
PRU
57
-2
Financhill
Back

BioStem Technologies, Inc. 10K Form

Sell
31

BSEM
BioStem Technologies, Inc.

Last Price:
$3.8400
Seasonality Move:
-2.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BSEM News And Ratings

See the #1 stock for the next 7 days that we like better than BSEM

BSEM Financial Statistics

Sales & Book Value

Annual Sales: $301.8M
Cash Flow: $0
Price / Cash Flow: 5.85
Annual Sales: $2.98
Price / Book: 1.3

Profitability

EPS (TTM): 0.84850
Net Income (TTM): $20.2M
Gross Margin: $287.9M
Return on Equity: 48.25%
Return on Assets: 17.75%

BioStem Technologies, Inc. Earnings Forecast

Key BioStem Technologies, Inc. Financial Ratios

  • The Gross Profit Margin over the past 15 years for BSEM is 95.37%.
  • The Selling, General & Administrative Expenses for BSEM have been equal to 84.40% of Gross Profit Margin.
  • The Research & Development expenses have been 0.63% of Revenue.
  • The Interest Expense is 1.84% of Operating Income.
  • The Net Earning history of BSEM is 10.56% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 10 years.

BioStem Technologies, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BSEM
Website: biostemtechnologies.com

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 4.31
Quick Ratio: 3.87

Price-to-Earnings

Trailing P/E Ratio: 2.63
Forward P/E Ratio: 13.34

BSEM Technical Analysis vs Fundamental Analysis

Sell
31
BioStem Technologies, Inc. (BSEM) is a Sell

Is BioStem Technologies, Inc. a Buy or a Sell?